メタボトロピックグルタミン酸受容体2のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Metabotropic Glutamate Receptor 2 Market Insights and Forecast to 2028

• レポートコード：QY2203B06583 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のメタボトロピックグルタミン酸受容体2の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にメタボトロピックグルタミン酸受容体2の世界市場のxxx％を占める「LY-2607540」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「不安障害」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のメタボトロピックグルタミン酸受容体2の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのメタボトロピックグルタミン酸受容体2市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのメタボトロピックグルタミン酸受容体2市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 メタボトロピックグルタミン酸受容体2のグローバル主要メーカーには、Addex Therapeutics Ltd、Bristol-Myers Squibb Company、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Johnson & Johnson、Merck & Co Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 メタボトロピックグルタミン酸受容体2市場は、種類と用途によって区分されます。世界のメタボトロピックグルタミン酸受容体2市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 LY-2607540、BMT-133218、DT-2442、JNJ-40411813、その他 【用途別セグメント】 不安障害、うつ病、統合失調症、慢性疼痛、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - メタボトロピックグルタミン酸受容体2製品概要 - 種類別市場（LY-2607540、BMT-133218、DT-2442、JNJ-40411813、その他） - 用途別市場（不安障害、うつ病、統合失調症、慢性疼痛、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のメタボトロピックグルタミン酸受容体2販売量予測2017-2028 - 世界のメタボトロピックグルタミン酸受容体2売上予測2017-2028 - メタボトロピックグルタミン酸受容体2の地域別販売量 - メタボトロピックグルタミン酸受容体2の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別メタボトロピックグルタミン酸受容体2販売量 - 主要メーカー別メタボトロピックグルタミン酸受容体2売上 - 主要メーカー別メタボトロピックグルタミン酸受容体2価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（LY-2607540、BMT-133218、DT-2442、JNJ-40411813、その他） - メタボトロピックグルタミン酸受容体2の種類別販売量 - メタボトロピックグルタミン酸受容体2の種類別売上 - メタボトロピックグルタミン酸受容体2の種類別価格 ・用途別市場規模（不安障害、うつ病、統合失調症、慢性疼痛、その他） - メタボトロピックグルタミン酸受容体2の用途別販売量 - メタボトロピックグルタミン酸受容体2の用途別売上 - メタボトロピックグルタミン酸受容体2の用途別価格 ・北米市場 - 北米のメタボトロピックグルタミン酸受容体2市場規模（種類別、用途別） - 主要国別のメタボトロピックグルタミン酸受容体2市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのメタボトロピックグルタミン酸受容体2市場規模（種類別、用途別） - 主要国別のメタボトロピックグルタミン酸受容体2市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のメタボトロピックグルタミン酸受容体2市場規模（種類別、用途別） - 主要国別のメタボトロピックグルタミン酸受容体2市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のメタボトロピックグルタミン酸受容体2市場規模（種類別、用途別） - 主要国別のメタボトロピックグルタミン酸受容体2市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのメタボトロピックグルタミン酸受容体2市場規模（種類別、用途別） - 主要国別のメタボトロピックグルタミン酸受容体2市場規模（トルコ、サウジアラビア） ・企業情報 Addex Therapeutics Ltd、Bristol-Myers Squibb Company、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Johnson & Johnson、Merck & Co Inc ・産業チェーン及び販売チャネル分析 - メタボトロピックグルタミン酸受容体2の産業チェーン分析 - メタボトロピックグルタミン酸受容体2の原材料 - メタボトロピックグルタミン酸受容体2の生産プロセス - メタボトロピックグルタミン酸受容体2の販売及びマーケティング - メタボトロピックグルタミン酸受容体2の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - メタボトロピックグルタミン酸受容体2の産業動向 - メタボトロピックグルタミン酸受容体2のマーケットドライバー - メタボトロピックグルタミン酸受容体2の課題 - メタボトロピックグルタミン酸受容体2の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Metabotropic Glutamate Receptor 2 Market
Due to the COVID-19 pandemic, the global Metabotropic Glutamate Receptor 2 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, LY-2607540 accounting for % of the Metabotropic Glutamate Receptor 2 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Anxiety Disorders segment is altered to an % CAGR throughout this forecast period.
China Metabotropic Glutamate Receptor 2 market size is valued at US$ million in 2021, while the US and Europe Metabotropic Glutamate Receptor 2 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Metabotropic Glutamate Receptor 2 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Metabotropic Glutamate Receptor 2 include Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson and Merck & Co Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Metabotropic Glutamate Receptor 2 Scope and Segment
Metabotropic Glutamate Receptor 2 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
LY-2607540
BMT-133218
DT-2442
JNJ-40411813
Others
Segment by Application
Anxiety Disorders
Depression
Schizophrenia
Chronic Pain
Others
By Company
Addex Therapeutics Ltd
Bristol-Myers Squibb Company
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Johnson & Johnson
Merck & Co Inc
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Metabotropic Glutamate Receptor 2 Product Introduction
1.2 Market by Type
1.2.1 Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 LY-2607540
1.2.3 BMT-133218
1.2.4 DT-2442
1.2.5 JNJ-40411813
1.2.6 Others
1.3 Market by Application
1.3.1 Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Anxiety Disorders
1.3.3 Depression
1.3.4 Schizophrenia
1.3.5 Chronic Pain
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 2 Sales Estimates and Forecasts 2017-2028
2.2 Global Metabotropic Glutamate Receptor 2 Revenue Estimates and Forecasts 2017-2028
2.3 Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Metabotropic Glutamate Receptor 2 Sales by Region
2.4.1 Global Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022)
2.4.2 Global Sales Metabotropic Glutamate Receptor 2 by Region (2023-2028)
2.5 Global Metabotropic Glutamate Receptor 2 Revenue by Region
2.5.1 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers
3.1.1 Global Top Metabotropic Glutamate Receptor 2 Manufacturers by Sales (2017-2022)
3.1.2 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metabotropic Glutamate Receptor 2 in 2021
3.2 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers
3.2.1 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (2017-2022)
3.2.2 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 2 Revenue in 2021
3.3 Global Metabotropic Glutamate Receptor 2 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Metabotropic Glutamate Receptor 2 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 2 Sales by Type
4.1.1 Global Metabotropic Glutamate Receptor 2 Historical Sales by Type (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 2 Forecasted Sales by Type (2023-2028)
4.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
4.2 Global Metabotropic Glutamate Receptor 2 Revenue by Type
4.2.1 Global Metabotropic Glutamate Receptor 2 Historical Revenue by Type (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 2 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
4.3 Global Metabotropic Glutamate Receptor 2 Price by Type
4.3.1 Global Metabotropic Glutamate Receptor 2 Price by Type (2017-2022)
4.3.2 Global Metabotropic Glutamate Receptor 2 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 2 Sales by Application
5.1.1 Global Metabotropic Glutamate Receptor 2 Historical Sales by Application (2017-2022)
5.1.2 Global Metabotropic Glutamate Receptor 2 Forecasted Sales by Application (2023-2028)
5.1.3 Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 2 Revenue by Application
5.2.1 Global Metabotropic Glutamate Receptor 2 Historical Revenue by Application (2017-2022)
5.2.2 Global Metabotropic Glutamate Receptor 2 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 2 Price by Application
5.3.1 Global Metabotropic Glutamate Receptor 2 Price by Application (2017-2022)
5.3.2 Global Metabotropic Glutamate Receptor 2 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Metabotropic Glutamate Receptor 2 Market Size by Type
6.1.1 North America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
6.1.2 North America Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
6.2 North America Metabotropic Glutamate Receptor 2 Market Size by Application
6.2.1 North America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
6.2.2 North America Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
6.3 North America Metabotropic Glutamate Receptor 2 Market Size by Country
6.3.1 North America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2028)
6.3.2 North America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 2 Market Size by Type
7.1.1 Europe Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
7.1.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
7.2 Europe Metabotropic Glutamate Receptor 2 Market Size by Application
7.2.1 Europe Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
7.2.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
7.3 Europe Metabotropic Glutamate Receptor 2 Market Size by Country
7.3.1 Europe Metabotropic Glutamate Receptor 2 Sales by Country (2017-2028)
7.3.2 Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size by Type
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
8.2 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size by Application
8.2.1 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
8.2.2 Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
8.3 Asia Pacific Metabotropic Glutamate Receptor 2 Market Size by Region
8.3.1 Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2017-2028)
8.3.2 Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 2 Market Size by Type
9.1.1 Latin America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
9.1.2 Latin America Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
9.2 Latin America Metabotropic Glutamate Receptor 2 Market Size by Application
9.2.1 Latin America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
9.2.2 Latin America Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
9.3 Latin America Metabotropic Glutamate Receptor 2 Market Size by Country
9.3.1 Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2028)
9.3.2 Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size by Type
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2028)
10.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size by Application
10.2.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2028)
10.3 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size by Country
10.3.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Addex Therapeutics Ltd Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Overview
11.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Denovo Biopharma LLC
11.3.1 Denovo Biopharma LLC Corporation Information
11.3.2 Denovo Biopharma LLC Overview
11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Denovo Biopharma LLC Recent Developments
11.4 Domain Therapeutics SA
11.4.1 Domain Therapeutics SA Corporation Information
11.4.2 Domain Therapeutics SA Overview
11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Domain Therapeutics SA Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Corporation Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly and Company Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Corporation Information
11.7.2 Merck & Co Inc Overview
11.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck & Co Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metabotropic Glutamate Receptor 2 Industry Chain Analysis
12.2 Metabotropic Glutamate Receptor 2 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metabotropic Glutamate Receptor 2 Production Mode & Process
12.4 Metabotropic Glutamate Receptor 2 Sales and Marketing
12.4.1 Metabotropic Glutamate Receptor 2 Sales Channels
12.4.2 Metabotropic Glutamate Receptor 2 Distributors
12.5 Metabotropic Glutamate Receptor 2 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Metabotropic Glutamate Receptor 2 Industry Trends
13.2 Metabotropic Glutamate Receptor 2 Market Drivers
13.3 Metabotropic Glutamate Receptor 2 Market Challenges
13.4 Metabotropic Glutamate Receptor 2 Market Restraints
14 Key Findings in The Global Metabotropic Glutamate Receptor 2 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of LY-2607540
Table 3. Major Manufacturers of BMT-133218
Table 4. Major Manufacturers of DT-2442
Table 5. Major Manufacturers of JNJ-40411813
Table 6. Major Manufacturers of Others
Table 7. Global Metabotropic Glutamate Receptor 2 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Metabotropic Glutamate Receptor 2 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2022)
Table 11. Global Metabotropic Glutamate Receptor 2 Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2023-2028)
Table 13. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2017-2022)
Table 15. Global Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region (2023-2028)
Table 17. Global Metabotropic Glutamate Receptor 2 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Metabotropic Glutamate Receptor 2 Sales Share by Manufacturers (2017-2022)
Table 19. Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturers (2017-2022)
Table 21. Metabotropic Glutamate Receptor 2 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Metabotropic Glutamate Receptor 2 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Metabotropic Glutamate Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2021)
Table 24. Metabotropic Glutamate Receptor 2 Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Metabotropic Glutamate Receptor 2 Product Offered
Table 26. Date of Manufacturers Enter into Metabotropic Glutamate Receptor 2 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Metabotropic Glutamate Receptor 2 Sales Share by Type (2017-2022)
Table 31. Global Metabotropic Glutamate Receptor 2 Sales Share by Type (2023-2028)
Table 32. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Metabotropic Glutamate Receptor 2 Revenue Share by Type (2017-2022)
Table 35. Global Metabotropic Glutamate Receptor 2 Revenue Share by Type (2023-2028)
Table 36. Metabotropic Glutamate Receptor 2 Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Metabotropic Glutamate Receptor 2 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Metabotropic Glutamate Receptor 2 Sales Share by Application (2017-2022)
Table 41. Global Metabotropic Glutamate Receptor 2 Sales Share by Application (2023-2028)
Table 42. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Metabotropic Glutamate Receptor 2 Revenue Share by Application (2017-2022)
Table 45. Global Metabotropic Glutamate Receptor 2 Revenue Share by Application (2023-2028)
Table 46. Metabotropic Glutamate Receptor 2 Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Metabotropic Glutamate Receptor 2 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Metabotropic Glutamate Receptor 2 Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue by Country (2023-2028) & (US$ Million)
Table 108. Addex Therapeutics Ltd Corporation Information
Table 109. Addex Therapeutics Ltd Description and Major Businesses
Table 110. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Addex Therapeutics Ltd Recent Developments
Table 113. Bristol-Myers Squibb Company Corporation Information
Table 114. Bristol-Myers Squibb Company Description and Major Businesses
Table 115. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Bristol-Myers Squibb Company Recent Developments
Table 118. Denovo Biopharma LLC Corporation Information
Table 119. Denovo Biopharma LLC Description and Major Businesses
Table 120. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Denovo Biopharma LLC Recent Developments
Table 123. Domain Therapeutics SA Corporation Information
Table 124. Domain Therapeutics SA Description and Major Businesses
Table 125. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Domain Therapeutics SA Recent Developments
Table 128. Eli Lilly and Company Corporation Information
Table 129. Eli Lilly and Company Description and Major Businesses
Table 130. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Eli Lilly and Company Recent Developments
Table 133. Johnson & Johnson Corporation Information
Table 134. Johnson & Johnson Description and Major Businesses
Table 135. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Johnson & Johnson Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Johnson & Johnson Recent Developments
Table 138. Merck & Co Inc Corporation Information
Table 139. Merck & Co Inc Description and Major Businesses
Table 140. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Merck & Co Inc Metabotropic Glutamate Receptor 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Merck & Co Inc Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Metabotropic Glutamate Receptor 2 Distributors List
Table 146. Metabotropic Glutamate Receptor 2 Customers List
Table 147. Metabotropic Glutamate Receptor 2 Market Trends
Table 148. Metabotropic Glutamate Receptor 2 Market Drivers
Table 149. Metabotropic Glutamate Receptor 2 Market Challenges
Table 150. Metabotropic Glutamate Receptor 2 Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 2 Product Picture
Figure 3. Global Metabotropic Glutamate Receptor 2 Market Share by Type in 2021 & 2028
Figure 3. LY-2607540 Product Picture
Figure 4. BMT-133218 Product Picture
Figure 5. DT-2442 Product Picture
Figure 6. JNJ-40411813 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metabotropic Glutamate Receptor 2 Market Share by Application in 2021 & 2028
Figure 9. Anxiety Disorders
Figure 10. Depression
Figure 11. Schizophrenia
Figure 12. Chronic Pain
Figure 13. Others
Figure 14. Metabotropic Glutamate Receptor 2 Report Years Considered
Figure 15. Global Metabotropic Glutamate Receptor 2 Sales 2017-2028 (K Pcs)
Figure 16. Global Metabotropic Glutamate Receptor 2 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Metabotropic Glutamate Receptor 2 Revenue 2017-2028 (US$ Million)
Figure 18. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2017-2022)
Figure 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Region (2023-2028)
Figure 21. North America Metabotropic Glutamate Receptor 2 Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Metabotropic Glutamate Receptor 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Metabotropic Glutamate Receptor 2 Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Metabotropic Glutamate Receptor 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Metabotropic Glutamate Receptor 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Metabotropic Glutamate Receptor 2 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Metabotropic Glutamate Receptor 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Metabotropic Glutamate Receptor 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Metabotropic Glutamate Receptor 2 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Metabotropic Glutamate Receptor 2 in the World: Market Share by Metabotropic Glutamate Receptor 2 Revenue in 2021
Figure 33. Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 35. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 36. Global Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 37. Global Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 38. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 39. North America Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 40. North America Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 41. North America Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 42. North America Metabotropic Glutamate Receptor 2 Sales Share by Country (2017-2028)
Figure 43. North America Metabotropic Glutamate Receptor 2 Revenue Share by Country (2017-2028)
Figure 44. U.S. Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 47. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 48. Europe Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 49. Europe Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 50. Europe Metabotropic Glutamate Receptor 2 Sales Share by Country (2017-2028)
Figure 51. Europe Metabotropic Glutamate Receptor 2 Revenue Share by Country (2017-2028)
Figure 52. Germany Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 53. France Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Metabotropic Glutamate Receptor 2 Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Metabotropic Glutamate Receptor 2 Revenue Share by Region (2017-2028)
Figure 63. China Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 66. India Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 74. Latin America Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 76. Latin America Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Metabotropic Glutamate Receptor 2 Sales Share by Country (2017-2028)
Figure 78. Latin America Metabotropic Glutamate Receptor 2 Revenue Share by Country (2017-2028)
Figure 79. Mexico Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Metabotropic Glutamate Receptor 2 Revenue Share by Country (2017-2028)
Figure 88. Turkey Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Metabotropic Glutamate Receptor 2 Revenue (2017-2028) & (US$ Million)
Figure 91. Metabotropic Glutamate Receptor 2 Value Chain
Figure 92. Metabotropic Glutamate Receptor 2 Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---